The influence of immunity on transformation into MLL-ENL–driven AML.

Slides:



Advertisements
Similar presentations
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of a Leukemic Stem Cell Gene Expression.
Advertisements

Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C
miRNAs regulated by c‐Myc in murine ES cells.
Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Volume 18, Issue 1, Pages (January 2016)
Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate.
Volume 17, Issue 2, Pages (August 2015)
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging by Matthias Edinger, Yu-An Cao, Michael R. Verneris,
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
by Hyung-Gyoon Kim, Kyoko Kojima, C. Scott Swindle, Claudiu V
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like.
Experimental Hematology
Distinct classes of c-Kit–activating mutations differ in their ability to promote RUNX1-ETO–associated acute myeloid leukemia by Heidi J. Nick, Hyung-Gyoon.
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
Volume 3, Issue 5, Pages (November 2014)
by Ute Koch, Anne Wilson, Monica Cobas, Rolf Kemler, H
Volume 15, Issue 6, Pages (June 2014)
Volume 4, Issue 1, Pages (January 2015)
The Branching Point in Erythro-Myeloid Differentiation
Yosuke Kamimura, Lewis L. Lanier  Cell Reports 
Megakaryocyte-derived excessive transforming growth factor β1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia  Yuemin.
Volume 4, Issue 4, Pages (October 2008)
Volume 13, Issue 5, Pages (May 2008)
Leukemia and chromosomal instability in aged Fancc−/− mice
Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions by Suparna Dutt, Michelle B. Atallah,
PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice  Denis R. Burger, Yvonne Parker, Kathryn.
Fig. 7 BRD0705 impairs colony formation in AML cell lines and patient cells and shows in vivo efficacy in multiple AML mouse models. BRD0705 impairs colony.
Volume 17, Issue 5, Pages (November 2015)
Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells by Fang Dong, Haitao.
VAY-736 combines effectively with ibrutinib in vivo.
Volume 14, Issue 12, Pages (March 2016)
Volume 22, Issue 2, Pages (January 2018)
STAT1 acts as a tumor promoter for leukemia development
Volume 11, Issue 3, Pages (September 2018)
Volume 18, Issue 4, Pages (October 2010)
Volume 11, Issue 2, Pages (August 1999)
Volume 27, Issue 3, Pages (September 2007)
Volume 15, Issue 3, Pages (April 2016)
David Traver, Koichi Akashi, Irving L. Weissman, Eric Lagasse  Immunity 
Volume 9, Issue 4, Pages (November 2014)
Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating.
Volume 33, Issue 4, Pages (October 2010)
A rapid, spontaneous, and fully penetrant model of cytogenetically normal AML utilizing Flt3ITD and Dnmt3a haploinsufficiency. A rapid, spontaneous, and.
Tim C.P. Somervaille, Michael L. Cleary  Cancer Cell 
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis  Talia Velasco-Hernandez, Petter.
Volume 4, Issue 2, Pages (February 2009)
Methods applied in addition
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 5, Issue 1, Pages (July 2009)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 2, Issue 1, Pages (January 2008)
Volume 3, Issue 2, Pages (February 2003)
Volume 1, Issue 2, Pages (August 2007)
Tobias Maetzig, Jens Ruschmann, Lea Sanchez Milde, Courteney K
Volume 21, Issue 12, Pages (December 2017)
HOXB6 overexpression results in delayed AML
SAP Protein-Dependent Natural Killer T-like Cells Regulate the Development of CD8+ T Cells with Innate Lymphocyte Characteristics  Mihalis Verykokakis,
Volume 17, Issue 4, Pages (October 2015)
The mucosal environment regulates CD160 expression on IELs
Volume 2, Issue 3, Pages (March 2008)
BAP1 is required for homeostatic and antigen-driven expansion of peripheral T cells. BAP1 is required for homeostatic and antigen-driven expansion of peripheral.
c-Rel expression in donor T cells is increased after allo-HSCT.
Summary data for target shift experiments and transient recall of old memories observed in the second target shift task. Summary data for target shift.
Transplants Facilitated by NMDP/Be The Match
Crebbp deficiency accelerates B-cell lymphoma development in mice.
In vivo efficacy of JAK inhibition in transformed Pax5+/− pro-B cells harboring Jak3V670A. In vivo efficacy of JAK inhibition in transformed Pax5+/− pro-B.
Ezh2 inactivation inhibits initiation/progression of CML and establishment of secondary leukemia from existing LICs. A, protocol for induction of Ezh2.
Presentation transcript:

The influence of immunity on transformation into MLL-ENL–driven AML. The influence of immunity on transformation into MLL-ENL–driven AML. (A) Overview of the experimental design. 1,000 preGMs were isolated from iME mice and transplanted into sublethally (350 cGy) irradiated WT, Rag2−/−, and Rag2−/−gc−/− mice. Upon disease development, splenic AML cells were isolated from WT and Rag2−/−gc−/− mice and transplanted at different doses (50,000, 100,000, or 300,000 leukemic cells) into sets of new sublethally irradiated WT, Rag2−/−, and Rag2−/−gc−/− hosts. (B) Total B or T cell numbers derived from iME preGMs in WT, Rag2−/−, and Rag2−/−gc−/− hosts during leukemia development. (C) The pattern of leukemia formation in WT (black lines) and Rag2−/− (green lines) hosts. Top graph, left: the amount of iME myeloid cells as a fraction of all myeloid cells in hosts, before leukemia development. Shown are the means ± SE. Bottom graph, left: the iME myeloid contribution in all WT and Rag2−/− hosts throughout the experiment (n = 21 recipients per group, from three separate experiments). Each line depicts an individual recipient. The pattern of leukemia formation in Rag2−/−gc−/− hosts. Top graph, right: the amount of iME myeloid cells as a fraction of all myeloid cells in hosts, before leukemia development. Shown are the means ± SE. The values in three individual mice in which iME expanded excessively are indicated in grey (these mice were censored from the summary represented by the red curve). Bottom graph, right: the iME myeloid contribution in all Rag2−/−gc−/− hosts throughout the experiment (n = 21 recipients, from three separate experiments). Each line depicts an individual recipient. (D) Kaplan–Meier survival curves of all transplanted primary mice. No significant difference in survival or disease latency was observed between any of the groups. Monika Dudenhöffer-Pfeifer, and David Bryder LSA 2018;1:e201800079 © 2018 Bryder and Dudenhöffer-Pfeifer